21 May 2009
Modified charlson comorbidity index in predicting early mortality after liver transplantation
M Wasilewicz, J Raszeja-Wyszomirska, M Wójcicki, P MilkiewiczAnn Transplant 2009; 14(1): 39-40 :: ID: 880341
Abstract
Background: Charlson Co morbidity Index-Orthotopic LT (CCI-OLT) is a modified clinical score recently found to be useful in the assessment of a long term survival after liver transplantation (LTx) (Volk et al. Liver Transplantation 2007). It includes 9 most important associated conditions selected in multivariate analysis on a large cohort of transplanted patients. Its role in predicting early mortality after LTx has not yet been investigated. Aim: Evaluation of CCI-OLT as a potential predictor of one-month mortality after LTx.
Material/Methods: A group of 169 consecutive patients (103 males and 67 females, median age in both groups 51 years) who received their elective LTx at our centre was analysed. Patients transplanted for fulminant hepatic failure were excluded from the analysis. Viral (39%) and alcohol induced (23%) cirrhosis were most common indications for LTx. CCI-OLT index was assessed in all patients. Statistical analysis was performed with StatView Program.
Results: 146 (86%) subjects survived and 23 (14%) died within 1 month after
LTx. Fifty one (30%) patients suffered from at least 1 co-morbidity included in CCI-OLT index, a number significantly lower than in population studied by Volk et al. Direct comparison of the groups of survivors and non-survivors showed no significant difference in terms of the total frequency of co-morbidities (30.1% vs. 30.4%, p>0.99), their number and type. The most common associated condition in both groups was diabetes mellitus.
Conclusions: Contrary to the long term survival, CCI-OLT does not seem to have a role as a predictor of early (one-month) mortality after LTx.
Keywords: Liver Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






